News
9h
ScienceAlert on MSNPromising New Drug For Weight Loss Works With Just One Monthly DoseDrugs such as Ozempic (a brand name for semaglutide) are showing promise for weight loss. Another medication in the same ...
StockStory.org on MSN13h
5 Insightful Analyst Questions From Amgen’s Q1 Earnings CallAmgen’s first quarter results reflected robust demand across its portfolio, with product volumes and sales increasing in both ...
What does the fracturing of vaccine advice and policy mean for the U.S. health care ecosystem? Will the potential head of the Centers for Disease Control ...
6h
Zacks Investment Research on MSNVKTX Initiates Phase 3 Study on Obesity Candidate VK2735Viking Therapeutics VKTX announced that it has initiated the phase III VANQUISH program, evaluating the subcutaneous (SC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results